JLE

Epileptic Disorders

MENU

Predictors of outcome among 31 children with infantile spasms syndrome Volume 24, numéro 2, April 2022

  • [1] Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst JM, Specchio N, Riney K, et al. ILAE classification & definition of epilepsy syndromes in the neonate and infant: position statement by the ILAE Task Force on Nosology and Definitions. ILAE. https://www.ilae.org/files/dmfile/Neonatal_Infantile_Finalapril5.pdf
  • [2] Fisher R.S., Cross J.H., D'Souza C., French J.A., Haut S.R., Higurashi N. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58:531-542. 4
  • [3] Messer R., Knupp K.G. Infantile spasms: opportunities to improve care. Semin Neurol. 2020;40:236-245. 2
  • [4] Lux A.L., Edwards S.W., Hancock E., Johnson A.L., Kennedy C.R., Newton R.W. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712-717. 11
  • [5] Pellock J.M., Hrachovy R., Shinnar S., Baram T.Z., Bettis D., Dlugos D.J. Infantile spasms: a U.S. consensus report. Epilepsia. 2010;51:2175-2189. 10
  • [6] Oguni H., Sugai K. Current problems of treatment for infantile spasms. No To Hattatsu. 2010;42:144-146. 2
  • [7] Partikian A., Mitchell W.G. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J Child Neurol. 2010;25:423-428. 4
  • [8] Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev. 2001;23:683-687. 7
  • [9] Kossoff E.H. Infantile spasms. Neurologist. 2010;16:69-75. 2
  • [10] Riikonen R. Infantile spasms: outcome in clinical studies. Pediatr Neurol. 2020;108:54-64.
  • [11] Bitton J.Y., Desnous B., Sauerwein H.C., Connolly M., Weiss S.K., Donner E.J. Cognitive outcome in children with infantile spasms using a standardized treatment protocol. A five-year longitudinal study. Seizure. 2021;89:73-80.
  • [12] Bolton P.F., Carcani-Rathwell I., Hutton J., Goode S., Howlin P., Rutter M. Epilepsy in autism: features and correlates. Br J Psychiatry. 2011;198:289-294. 4
  • [13] Wilmshurst J.M., Gaillard W.D., Vinayan K.P., Tsuchida T.N., Plouin P., Van Bogaert P. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015;56:1185-1197. 8
  • [14] Bitton J.Y., Demos M., Elkouby K., Connolly M., Weiss S.K., Donner E.J. Does treatment have an impact on incidence and risk factors for autism spectrum disorders in children with infantile spasms? Epilepsia. 2015;56:856-863. 6
  • [15] Hardy S., Haisley L., Manning C., Fein D. Can screening with the ages and stages questionnaire detect autism? J Dev Behav Pediatr. 2015;36:536-543. 7
  • [16] Jones K., Go C., Boyd J., Ochi A., McCoy B., Puka K. Vigabatrin as first-line treatment for infantile spasms not related to tuberous sclerosis complex. Pediatr Neurol. 2015;53:141-145. 2
  • [17] Lamsal R., Dutton D.J., Zwicker J.D. Using the ages and stages questionnaire in the general population as a measure for identifying children not at risk of a neurodevelopmental disorder. BMC Pediatr. 2018;18:122. 1
  • [18] Jasper H.H. The ten±twenty electrode system of the International Federation. Electroenceph Clin Neurophysiol. 1958;10:371-375.
  • [19] Kobayashi K., Oka M., Inoue T., Ogino T., Yoshinaga H., Ohtsuka Y. Characteristics of slow waves on EEG associated with epileptic spasms. Epilepsia. 2005;46:1098-1105. 7
  • [20] Vigevano F., Cilio M.R. Adrenocorticotropic hormone and corticosteroids – ch. 32. In: Shorvon S., Perucca E., Engel J. Jr., eds. The treatment of epilepsy. Wiley Online Library; 2009. 3rd ed
  • [21] Kvernadze A., Tatishvili N., Kipiani T., Lomidze G. Characteristics of West syndrome in Georgia, preliminary results of the prospective study. Georgian Med News. 2017;11:104-109. 272
  • [22] Riikonen R.S. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol. 2010;14:13-18. 1
  • [23] Hussain S.A. Treatment of infantile spasms. Epilepsia Open. 2018;3:143-154. 6
  • [24] Güveli B.T., Çokar Ö., Dörtcan N., Benbir G., Demirbilek V., Dervent A. Long-term outcomes in patients with West syndrome: an outpatient clinical study. Seizure. 2015;25:68-71.
  • [25] Karvelas G., Lortie A., Scantlebury M.H., Duy P.T., Cossette P., Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure. 2009;18:197-201. 3
  • [26] Fusco L., Serino D., Santarone M.E. Three different scenarios for epileptic spasms. Epilepsy Behav. 2020;113:107531.
  • [27] Oh S.H., Lee E.H., Joung M.H., Yum M.S., Ko T.S. Long-term outcomes of infantile spasms. Korean J Pediatr. 2010;53:80-84. 1
  • [28] Glaze D.G., Hrachovy R.A., Frost J.D., Kellaway P., Zion T.E. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone. J Pediatr. 1988;112:389-396. 3
  • [29] Hamano S.I., Tanaka M., Mochizuki M., Sugiyama N., Eto Y. Long-term follow-up study of West syndrome: differences of outcome among symptomatic etiologies. J Pediatr. 2003;143:231-235. 2
  • [30] Paciorkowski A.R., Thio L.L., Dobyns W.B. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355-367. 6
  • [31] Michaud J.L., Lachance M., Hamdan F.F., Carmant L., Lortie A., Diadori P. The genetic landscape of infantile spasms. Hum Mol Genet. 2014;23:4846-4858. 18
  • [32] Muir A.M., Myers C.T., Nguyen N.T., Saykally J., Craiu D., De Jonghe P. Genetic heterogeneity of infantile spasms. Epilepsy Res. 2019;156:106181.
  • [33] Riikonen R. Combination therapy for treatment of infantile spasms. Lancet Neurol. 2017;16:19. 1
  • [34] O’Callaghan F.J.K., Edwards S.W., Alber F.D., Hancock E., Johnson A.L., Kennedy C.R. Safety and effectiveness of hormonal treatment hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017;16:33. versus1
  • [35] Shields W.D. Infantile spasms: little seizures, big consequences. Epilepsy Curr. 2006;6:63-69. 3
  • [36] Dressler A., Benninger F., Trimmel-Schwahofer P., Gröppel G., Porsche B., Abraham K. Efficacy and tolerability of the ketogenic diet high-dose adrenocorticotropic hormone for infantile spasms: a single-center parallel-cohort randomized controlled trial. Epilepsia. 2019;60:441-451. versus3
  • [37] Hahn J., Park G., Kang H.-C., Lee J.S., Kim H.D., Kim S.H. Optimized treatment for infantile spasms: vigabatrin prednisolone combination therapy. J Clin Med. 2019;8:1591. versusversus10